BrainsWay has unveiled promising clinical data from a study showing that its Deep Transcranial Magnetic Stimulation therapy significantly reduces pain as well as symptoms of anxiety and depression in ...

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in ...

A Chicago nurse has been liberated from her own mind, thanks to a brain-tapping technology called deep TMS. Gulden, who requested to omit her surname for privacy reasons, worked as a nurse for more ...

Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.

BrainsWay Ltd. BWAY recently announced an expansion of insurance coverage for its Deep TMS therapy in adolescent depression. The update signals growing payer confidence in non-drug neurostimulation ...

Moment of Clarity has published a new educational resource titled “How Deep TMS Therapy Works,” providing a comprehensive overview of transcranial magnetic stimulation (TMS) and its emerging role in ...

BURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

NEW YORK, March 13, 2026 /PRNewswire/ -- Radial today announced publication of a landmark study showing accelerated Deep TMS can treat depression in six days instead of months. The research evaluated ...